T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. 1981

A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura

IgG-secretion was induced in a human B blastoid cell line, CESS, by the addition of partially purified T cell-derived helper factor(s) (TRF), which had been obtained from PHA-stimulated human T cells. The number of IgG-producing cells in CESS cells reached its maximal level (10% of total cells) within 48 hr after the addition of TRF. TRF did not affect the proliferation of CESS cells and the block of cell proliferation with hydroxyurea did not inhibit the increase of IgG-producing cells, showing that TRF induced IgG-production in CESS cells without any requirement of cell division. TRF activity was completely removed by CESS cells but TCGF-activity in the same preparation was not absorbed with CESS cells. On the other hand, TCGF-dependent human killer cells absorbed TCGF activity but not TRF activity in the same preparation. The binding of 125I-labeled factor(s) on CESS cells was also demonstrated. These results showed the presence of acceptors for TRF on the surface of CESS cells and this cell line will provide useful means for the chemical characterization of acceptors and for the study of the mechanisms of the signal transmission through acceptors.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007185 Incubators Insulated enclosures in which temperature, humidity, and other environmental conditions can be regulated at levels optimal for growth, hatching, reproduction, or metabolic reactions. Incubator
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006918 Hydroxyurea An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxycarbamid,Hydrea,Oncocarbide
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.

Related Publications

A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
January 1983, European journal of immunology,
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
April 1982, Journal of immunology (Baltimore, Md. : 1950),
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
May 1980, Journal of immunology (Baltimore, Md. : 1950),
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
December 1980, Journal of immunology (Baltimore, Md. : 1950),
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
January 1985, Lymphokine research,
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
January 1985, Journal of immunology (Baltimore, Md. : 1950),
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
June 1982, Journal of immunology (Baltimore, Md. : 1950),
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
June 1985, Journal of immunology (Baltimore, Md. : 1950),
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
July 1986, Journal of immunology (Baltimore, Md. : 1950),
A Muraguchi, and T Kishimoto, and Y Miki, and T Kuritani, and T Kaieda, and K Yoshizaki, and Y Yamamura
February 1982, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!